Home » J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax
J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax
November 20, 2013
A jury in Philadelphia ordered Janssen to fork over $11 million over allegations that its seizure drug Topamax caused birth defects.
Bloomberg
Bloomberg
Upcoming Events
-
21Oct